Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Motixafortide clinical trials
7 selected ClinicalTrials.gov records carrying the official matched intervention Motixafortide (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
7 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 9 selected PubMed records and 1 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT04543071
PeptideScanner retained ClinicalTrials.gov record NCT04543071 at 2026-11-16T01:39:10.285Z. Its registry update date was 2026-09-21, and PeptideScanner's reviewed identity mapping was motixafortide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 21, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05618301
PeptideScanner retained ClinicalTrials.gov record NCT05618301 at 2026-11-16T01:39:10.285Z. Its registry update date was 2025-08-11, and PeptideScanner's reviewed identity mapping was motixafortide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- August 11, 2025
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06442761
PeptideScanner retained ClinicalTrials.gov record NCT06442761 at 2026-11-16T01:39:10.285Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was motixafortide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 8, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Motixafortide · 2026-10-15
ClinicalTrials.gov record NCT06506461
Recruiting at the retained observation.
Open attributed record →Motixafortide · 2026-09-21
ClinicalTrials.gov record NCT04543071
Active, not recruiting at the retained observation.
Open attributed record →Motixafortide · 2026-09-08
ClinicalTrials.gov record NCT06442761
Recruiting at the retained observation.
Open attributed record →Motixafortide · 2026-07-24
ClinicalTrials.gov record NCT07392970
Recruiting at the retained observation.
Open attributed record →Motixafortide · 2026-07-23
ClinicalTrials.gov record NCT07101445
Recruiting at the retained observation.
Open attributed record →Motixafortide · 2025-08-29
ClinicalTrials.gov record NCT06547112
Completed at the retained observation.
Open attributed record →Motixafortide · 2025-08-11
ClinicalTrials.gov record NCT05618301
Completed at the retained observation.
Open attributed record →